• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变与血液血清素浓度

Central Serous Chorioretinopathy and Blood Serotonin Concentrations.

作者信息

Kimura Takeshi, Araki Takashi, Komuku Yuki, Iwami Hisashi, Gomi Fumi

机构信息

Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya 6638501, Japan.

出版信息

J Clin Med. 2021 Feb 3;10(4):558. doi: 10.3390/jcm10040558.

DOI:10.3390/jcm10040558
PMID:33546112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7913142/
Abstract

BACKGROUND

To investigate blood serotonin (5-hydroxytryptamine (5-HT)) concentrations and their relationships with selected characteristics in patients with central serous chorioretinopathy (CSC).

METHODS

This was a prospective study including 93 patients with active CSC. Blood concentrations of 5-HT, adrenocorticotropic hormone, and cortisol were measured in patients with CSC. Selected patient characteristics, including disease history (acute or chronic), medication use, smoking history, mood status, best-corrected visual acuity (BCVA), subfoveal choroidal thickness (SCT), findings on fluorescein and indocyanine green angiography, and anatomical changes were evaluated during follow-up.

RESULTS

Eleven of the 93 patients had low 5-HT concentrations (<57 ng/mL) (12%, eight men and three women; mean age 55 years); we identified no significant relationship with acute/chronic disease status. The patients with low 5-HT were significantly more likely to have five or more fluorescein leakage sites ( = 0.0275), recurrence of subretinal fluids ( < 0.0001), and failure to achieve significant improvement in BCVA during follow-up ( = 0.862) than patients with 5-HT within the normal range.

CONCLUSIONS

Blood serotonin concentrations may influence the pathophysiology and prognosis of CSC.

摘要

背景

研究中心性浆液性脉络膜视网膜病变(CSC)患者的血液血清素(5-羟色胺(5-HT))浓度及其与特定特征的关系。

方法

这是一项前瞻性研究,纳入93例活动性CSC患者。检测CSC患者血液中5-HT、促肾上腺皮质激素和皮质醇的浓度。在随访期间评估选定的患者特征,包括病史(急性或慢性)、用药情况、吸烟史、情绪状态、最佳矫正视力(BCVA)、黄斑下脉络膜厚度(SCT)、荧光素和吲哚菁绿血管造影结果以及解剖学变化。

结果

93例患者中有11例5-HT浓度较低(<57 ng/mL)(12%,8名男性和3名女性;平均年龄55岁);我们未发现其与急性/慢性疾病状态有显著关系。与5-HT浓度在正常范围内的患者相比,5-HT浓度低的患者更有可能有五个或更多荧光素渗漏部位(P = 0.0275)、视网膜下液复发(P < 0.0001)以及在随访期间BCVA未实现显著改善(P = 0.862)。

结论

血液血清素浓度可能影响CSC的病理生理学和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/76b0f2e517dd/jcm-10-00558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/e67d32e292de/jcm-10-00558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/8c6f48da8c24/jcm-10-00558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/76b0f2e517dd/jcm-10-00558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/e67d32e292de/jcm-10-00558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/8c6f48da8c24/jcm-10-00558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a444/7913142/76b0f2e517dd/jcm-10-00558-g003.jpg

相似文献

1
Central Serous Chorioretinopathy and Blood Serotonin Concentrations.中心性浆液性脉络膜视网膜病变与血液血清素浓度
J Clin Med. 2021 Feb 3;10(4):558. doi: 10.3390/jcm10040558.
2
Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.荧光素血管造影引导与吲哚菁绿血管造影引导半时光动力疗法治疗中心性浆液性脉络膜视网膜病变的疗效比较。
Photodiagnosis Photodyn Ther. 2020 Sep;31:101955. doi: 10.1016/j.pdpdt.2020.101955. Epub 2020 Aug 18.
3
Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.具有 1 型脉络膜新生血管的中心性浆液性脉络膜视网膜病变的临床特征。
Am J Ophthalmol. 2018 Sep;193:80-86. doi: 10.1016/j.ajo.2018.06.009. Epub 2018 Jun 27.
4
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.三分之一剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的临床研究。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):278-284. doi: 10.26355/eurrev_201801_14169.
5
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.通过增强深度成像和扫频源光学相干断层扫描测量中心性浆液性脉络膜视网膜病变的脉络膜厚度
BMC Ophthalmol. 2014 Nov 25;14:145. doi: 10.1186/1471-2415-14-145.
6
Choroidal Thickness Changes After Photodynamic Therapy and Recurrence of Chronic Central Serous Chorioretinopathy.光动力疗法后脉络膜厚度变化与慢性中心性浆液性脉络膜视网膜病变的复发
Am J Ophthalmol. 2015 Jul;160(1):72-84.e1. doi: 10.1016/j.ajo.2015.04.011. Epub 2015 Apr 14.
7
Clinical characteristics of central serous chorioretinopathy in patients by age.按年龄划分的中心性浆液性脉络膜视网膜病变患者的临床特征。
Jpn J Ophthalmol. 2021 Nov;65(6):761-768. doi: 10.1007/s10384-021-00861-5. Epub 2021 Aug 13.
8
Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量光动力治疗后的微视野变化及固视稳定性状态
Eur J Ophthalmol. 2020 Sep;30(5):1053-1060. doi: 10.1177/1120672119858877. Epub 2019 Jul 1.
9
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.急性中心性浆液性脉络膜视网膜病变:影响病程持续时间的因素
Retina. 2017 Oct;37(10):1905-1915. doi: 10.1097/IAE.0000000000001443.
10
Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者脉络膜新生血管的 3 年随访。
Br J Ophthalmol. 2020 Nov;104(11):1561-1566. doi: 10.1136/bjophthalmol-2019-315302. Epub 2020 Feb 12.

引用本文的文献

1
Pupillary Light Reflex and Multimodal Imaging in Patients With Central Serous Chorioretinopathy.瞳孔对光反射和多模态成像在中心性浆液性脉络膜视网膜病变患者中的应用。
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):28. doi: 10.1167/iovs.64.13.28.
2
A Review of Central Serous Chorioretinopathy: Clinical Presentation and Management.中心性浆液性脉络膜视网膜病变综述:临床表现与治疗
Cureus. 2022 Aug 13;14(8):e27965. doi: 10.7759/cureus.27965. eCollection 2022 Aug.
3
Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

本文引用的文献

1
Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变患者血浆细胞因子水平的改变。
Acta Ophthalmol. 2021 Mar;99(2):e222-e231. doi: 10.1111/aos.14547. Epub 2020 Jul 23.
2
Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变的应激与视觉相关生活质量。
BMC Ophthalmol. 2020 Mar 6;20(1):90. doi: 10.1186/s12886-020-01361-9.
3
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
中心性浆液性脉络膜视网膜病变的病理生理学:文献回顾及质量评估。
Eye (Lond). 2022 May;36(5):941-962. doi: 10.1038/s41433-021-01808-3. Epub 2021 Oct 15.
依普利酮治疗活动期、未经治疗超过 4 个月的慢性中心性浆液性脉络膜视网膜病变(VICI)患者:一项随机、双盲、安慰剂对照试验。
Lancet. 2020 Jan 25;395(10220):294-303. doi: 10.1016/S0140-6736(19)32981-2.
4
Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.持续性或复发性中心性浆液性脉络膜视网膜病变的危险因素。
J Ophthalmol. 2019 Aug 14;2019:5970659. doi: 10.1155/2019/5970659. eCollection 2019.
5
Elevated Steroid Hormone Levels in Active Chronic Central Serous Chorioretinopathy.活动性慢性中心性浆液性脉络膜视网膜病变患者类固醇激素水平升高。
Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3407-3413. doi: 10.1167/iovs.19-26781.
6
Reduced Blood Serotonin Levels in Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者血清5-羟色胺水平降低
Ophthalmol Retina. 2017 Mar-Apr;1(2):145-148. doi: 10.1016/j.oret.2016.09.003. Epub 2016 Nov 19.
7
Central serous chorioretinopathy with and without steroids: A multicenter survey.伴有和不伴有类固醇的中心性浆液性脉络膜视网膜病变:一项多中心调查。
PLoS One. 2019 Feb 28;14(2):e0213110. doi: 10.1371/journal.pone.0213110. eCollection 2019.
8
Investigating the Hypothesis of Stress System Dysregulation as a Risk Factor for Central Serous Chorioretinopathy: A Literature Mini-Review.探讨应激系统失调假说作为中心性浆液性脉络膜视网膜病变的风险因素:文献综述。
Curr Eye Res. 2019 Jun;44(6):583-589. doi: 10.1080/02713683.2019.1565891. Epub 2019 Jan 28.
9
The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.中心性浆液性脉络膜视网膜病变、脉络膜厚度与血清激素水平之间的关系。
Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1111-1116. doi: 10.1007/s00417-018-3985-x. Epub 2018 Apr 18.
10
Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变中的库欣综合征与下丘脑-垂体-肾上腺轴功能亢进
Front Endocrinol (Lausanne). 2018 Feb 20;9:39. doi: 10.3389/fendo.2018.00039. eCollection 2018.